Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health

Abstract

Two recent meta-analyses of randomised salt reduction trials have concluded that there is little purpose in reducing salt intake in the general population. However, the authors, as with other previous meta-analyses, included trials of very short duration (eg 1 week or less) and trials of acute salt loading followed by abrupt reductions to very low salt intake (eg from 20 to less than 1 g of salt/day). These acute salt loading and salt depletion experiments are known to increase sympathetic tone, and with salt depletion cause a rise in renin release and, thereby, plasma angiotensin II. These trials are not appropriate, therefore, for helping to inform public health policy, which is for a more modest reduction in salt intake, ie, from a usual intake of E10 to E5 g of salt per day over a more prolonged period of time. We carried out a meta-analysis to assess the effect of a modest salt reduction on blood pressure. Our data sources were MEDLINE, EMBASE, Cochrane library, CINAHL, and the reference lists of original and review articles. We included randomised trials with a modest reduction in salt intake and a duration of 4 or more weeks. Meta-analysis, meta-regression, and funnel plots were performed. A total of 17 trials in hypertensives (n ¼ 734) and 11 trials in normotensives (n ¼ 2220) were included in our study. The median reduction in 24-h urinary sodium excretion was 78 mmol (equivalent to 4.6 g of salt/day) in hypertensives and 74 mmol in normotensives. The pooled estimates of blood pressure fall were 4.96/2.73 7 0.40/0.24 mmHg in hypertensives (Po0.001 for both systolic and diastolic) and 2.03/ 0.97 7 0.27/0.21 mmHg in normotensives (Po0.001 for both systolic and diastolic). Weighted linear regression analyses showed a dose response between the change in urinary sodium and blood pressure. A reduction of 100 mmol/day (6 g of salt) in salt intake predicted a fall in blood pressure of 7.11/3.88 mmHg (Po0.001 for both systolic and diastolic) in hypertensives and 3.57/ 1.66 mmHg in normotensive individuals (systolic: Po0.001; diastolic: Po0.05). Our results demonstrate that a modest reduction in salt intake for a duration of 4 or more weeks does have a significant and, from a population viewpoint, important effect on blood pressure in both hypertensive and normotensive individuals. This meta-analysis strongly supports other evidence for a modest and long-term reduction in population salt intake, and would be predicted to reduce stroke deaths immediately by E14% and coronary deaths by E9% in hypertensives, and reduce stroke and coronary deaths by E6 and E4%, in normotensives, respectively.

Labelling the salt content in foods: a useful tool in reducing sodium intake in Finland

“…The public health impact of lowering salt intake in the population by just 2-3 g is significant based on several meta-analyses [15][16][17][18][19][20] . The most powerful evidence comes from two recent studies.…”

The feasibility and acceptability of reducing salt in partially baked bread: a Spanish case study

“…Many studies have confirmed that a moderate reduction in dietary salt can have great advantages for public health, in both the short (9) and the long term (10) .…”

Dietary salt consumption and the knowledge, attitudes and behavior of healthy adults: a cross-sectional study from Jordan

“…Therefore, the WHO has acknowledged high sodium intake as one of the silent killers of humans responsible for roughly 2.3 million deaths (4% of global mortality) in 2010 [1]. In a meta-analysis of 31 trials, reduction of sodium consumption by 75 mmol/day (equivalent to 4 g salt) resulted in an average decrease of 5.0 mmHg systolic blood pressure (BP) and 2.7 mmHg diastolic BP in hypertensive patients [9]. On the other hand, high potassium consumption has been found to be beneficial in preventing hypertension and cardiovascular events [10].…”